HB
GILD icon

Horizon Bancorp’s Gilead Sciences GILD Stock Holding History

Horizon Bancorp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$287K Buy
4,545
+367
+9% +$25.4K 0.41% 69
2020
Q2 		$321K Sell
4,178
-1,075
-20% -$82.4K 0.34% 54
2020
Q1 		$393K Sell
5,253
-337
-6% -$23.3K 0.61% 45
2019
Q4 		$363K Buy
+5,590
New +$364K 0.34% 82

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Horizon Bancorp's GILD Position: Q3 2020 in Review

Horizon Bancorp increased its Gilead Sciences (GILD) stake by 8.8% in Q3 2020, buying an estimated $25.4K and bringing the position to 4,545 shares worth $287K. The position accounts for 0.41% of the portfolio, ranked #69.

Horizon Bancorp first reported a position in GILD in Q4 2019 and has held it in 4 quarters since. The position peaked at $393K in Q1 2020. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Horizon Bancorp held 4,545 shares of Gilead Sciences worth $287K as of Q3 2020.
  • Horizon Bancorp bought 367 Gilead Sciences shares in Q3 2020, an estimated $25.4K.
  • Gilead Sciences made up 0.41% of Horizon Bancorp's portfolio in Q3 2020, its #69 holding.
  • Horizon Bancorp first reported a position in Gilead Sciences in Q4 2019 and has held it in 4 quarters since.
  • Horizon Bancorp's Gilead Sciences position peaked at $393K in Q1 2020.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Horizon Bancorp's 13F filing for Q3 2020, filed 12 Nov 2020.